Budapest Information Day
Budapest, March 27 2007
An Information Day titled "Cooperation with Canada in the EU FP7" was organized at Canadian Embassy in Budapest on March 27, 2007 in order to stimulate collaborative partnerships within the context of the Seventh Framework Programme and to determine areas of potential cooperation and projects in which Canada can play a role with local partners.
Participants included:
representatives of universities' R&D offices, research centres, institutes of the Hungarian Academy of Science (HAS), national and regional innovation agencies, S&T department of different ministries, industry associations and innovative companies.
The conference was very successful with almost forty attendees. One Canadian and six Hungarian speakers were invited to cover all aspects of potential S&T cooperation with a focus on two priority areas, ICT and biotechnology where Hungary has had some notable success stories.
There were proposals for concrete cooperation in specific areas and the participants could get familiar with projects in which Canadian partners are already involved or could be involved in the future.
Speakers included:
Pat Ockwell, Counsellor in Science and Technology of the Mission of Canada to the European Union in Brussels spoke on how to best build on or take part in opportunities offered though FP7. Participants were informed about the funding programs and the tools available for collaboration including the ERA-Can office located in Ottawa that provides a “one stop shop” to help Canadian and European researchers to establish links with each other.
Tivadar Lippenyi, the Regional Vice-President of the National Research and Technology Office gave a snapshot of Hungarian R&D funding (0.95% of its GDP) and discussed the new national innovation strategy that has just been finalized and is soon to be passed by Parliament. Priority S&T areas include ICT, life sciences and biotech, vehicle automation research, agro-food and nanotechnology. It was also mentioned that there was a Hungarian Office for Research and Development in Brussels (HunOR) - to complement the ERA-Can Office, - with the mission to facilitate successful participation of Hungary in the Seventh Framework Programme.
Dr. Edit Halasz, Associate Professor of the Budapest University of Technology and Economics (BME) presented the IST-EC2 project dedicated to establishing a bridge between Canadian and European partners in the Information Society Technologies (IST/ICT) in R&D projects.
Erno Duda, Director of the Hungarian Biotech Association gave a presentation on the success of Hungarian researchers in biotech. He presented success stories of Hungarian companies, such as the Kinase Inhibitory company, specialized in cancer research (melanoma), the licence of which was acquired in 2006 by Caprion Pharmaceuticals of Canada.
The last two lecturers from the Biological Research Centre of the Hungarian Academy of Sciences (HAS) from Szeged approached the biotech research applications from two different aspects. Gyula Hadlaczky, Scientific Advisor of the Institute of Genetics presented the artificial chromosome research program, the cooperation with the Canadian Chromos company. Following that, Kornel Kovacs, Senior Scientific Advisor of the Institute of Biophysics gave a presentation about biotech applications approaching the subject from the aspects of renewable energy and environment protection including the hydrogen-fuelled zero-emission vehicles, the use of solar energy, biogas and its challenges.
The presentations were followed by a lunch hosted by Ambassador Robert Hage and the Trade Commissioner Service where Mr. Zavodszky the Director of Hungarian Innovation Foundation evaluated the present state of the Hungarian innovation and compared it with the Canadian scientific and technological situation.
View two presentations held during the S&T Information Day:
Pat Ockwell, S&T Counsellor to the EU
Presentation on Canada’s involvement in the EU’s FP7
Ms. Edit Halász, Associate Professor, Budapest University of Technology and Economics
Bridge between Hungarian (European) and Canadian researchers in ICT
(Partly Hungarian - partly English)
Participants included:
representatives of universities' R&D offices, research centres, institutes of the Hungarian Academy of Science (HAS), national and regional innovation agencies, S&T department of different ministries, industry associations and innovative companies.
The conference was very successful with almost forty attendees. One Canadian and six Hungarian speakers were invited to cover all aspects of potential S&T cooperation with a focus on two priority areas, ICT and biotechnology where Hungary has had some notable success stories.
There were proposals for concrete cooperation in specific areas and the participants could get familiar with projects in which Canadian partners are already involved or could be involved in the future.
Speakers included:
Pat Ockwell, Counsellor in Science and Technology of the Mission of Canada to the European Union in Brussels spoke on how to best build on or take part in opportunities offered though FP7. Participants were informed about the funding programs and the tools available for collaboration including the ERA-Can office located in Ottawa that provides a “one stop shop” to help Canadian and European researchers to establish links with each other.
Tivadar Lippenyi, the Regional Vice-President of the National Research and Technology Office gave a snapshot of Hungarian R&D funding (0.95% of its GDP) and discussed the new national innovation strategy that has just been finalized and is soon to be passed by Parliament. Priority S&T areas include ICT, life sciences and biotech, vehicle automation research, agro-food and nanotechnology. It was also mentioned that there was a Hungarian Office for Research and Development in Brussels (HunOR) - to complement the ERA-Can Office, - with the mission to facilitate successful participation of Hungary in the Seventh Framework Programme.
Dr. Edit Halasz, Associate Professor of the Budapest University of Technology and Economics (BME) presented the IST-EC2 project dedicated to establishing a bridge between Canadian and European partners in the Information Society Technologies (IST/ICT) in R&D projects.
Erno Duda, Director of the Hungarian Biotech Association gave a presentation on the success of Hungarian researchers in biotech. He presented success stories of Hungarian companies, such as the Kinase Inhibitory company, specialized in cancer research (melanoma), the licence of which was acquired in 2006 by Caprion Pharmaceuticals of Canada.
The last two lecturers from the Biological Research Centre of the Hungarian Academy of Sciences (HAS) from Szeged approached the biotech research applications from two different aspects. Gyula Hadlaczky, Scientific Advisor of the Institute of Genetics presented the artificial chromosome research program, the cooperation with the Canadian Chromos company. Following that, Kornel Kovacs, Senior Scientific Advisor of the Institute of Biophysics gave a presentation about biotech applications approaching the subject from the aspects of renewable energy and environment protection including the hydrogen-fuelled zero-emission vehicles, the use of solar energy, biogas and its challenges.
The presentations were followed by a lunch hosted by Ambassador Robert Hage and the Trade Commissioner Service where Mr. Zavodszky the Director of Hungarian Innovation Foundation evaluated the present state of the Hungarian innovation and compared it with the Canadian scientific and technological situation.
View two presentations held during the S&T Information Day:
Pat Ockwell, S&T Counsellor to the EU
Presentation on Canada’s involvement in the EU’s FP7
Ms. Edit Halász, Associate Professor, Budapest University of Technology and Economics
Bridge between Hungarian (European) and Canadian researchers in ICT
(Partly Hungarian - partly English)
Forgot your password?
CANARIE’s Network-Enabled Platforms Workshop
IST-EC2 is supported in Europe by the European Commission
IST-EC2 is supported in Canada by key Federal Government Departments and Agencies, 